Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,690.26 -974.19 (-1.58%) CMC Crypto 200
1,263.97 -19.86 (-1.55%)
Astellas Pharma Inc. (4503.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
Currency in JPY
Valuation measures4
| Market cap (intra-day) | 2.85T |
| Enterprise value | 3.41T |
| Trailing P/E | 167.90 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.78 |
| Price/book (mrq) | 1.79 |
| Enterprise value/revenue | 2.12 |
| Enterprise value/EBITDA | 17.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.30 |
| 52-week change 3 | -25.86% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 2,270.00 |
| 52-week low 3 | 1,426.00 |
| 50-day moving average 3 | 1,533.42 |
| 200-day moving average 3 | 1,706.71 |
Share statistics
| Avg vol (3-month) 3 | 7.78M |
| Avg vol (10-day) 3 | 7.06M |
| Shares outstanding 5 | 1.79B |
| Implied shares outstanding 6 | 1.8B |
| Float 8 | 1.73B |
| % held by insiders 1 | 0.25% |
| % held by institutions 1 | 51.50% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 74 |
| Forward annual dividend yield 4 | 4.65% |
| Trailing annual dividend rate 3 | 70.00 |
| Trailing annual dividend yield 3 | 4.38% |
| 5-year average dividend yield 4 | 2.75 |
| Payout ratio 4 | 739.18% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 27 Sept 2024 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 27 Mar 2014 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 1.06% |
| Operating margin (ttm) | 14.41% |
Management effectiveness
| Return on assets (ttm) | 2.58% |
| Return on equity (ttm) | 1.10% |
Income statement
| Revenue (ttm) | 1.6T |
| Revenue per share (ttm) | 894.27 |
| Quarterly revenue growth (yoy) | 17.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 282.45B |
| Net income avi to common (ttm) | 17.05B |
| Diluted EPS (ttm) | 9.54 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 364.47B |
| Total cash per share (mrq) | 203.26 |
| Total debt (mrq) | 1.01T |
| Total debt/equity (mrq) | 63.15% |
| Current ratio (mrq) | 0.93 |
| Book value per share (mrq) | 890.07 |
Cash flow statement
| Operating cash flow (ttm) | 172.48B |
| Levered free cash flow (ttm) | 143.67B |
© 2024 Yahoo. All rights reserved.